Abstract：
OBJECTIVE: Morel-Lavallée lesion (MLL) is a closed soft-tissue degloving injurie resulting from shear forces. With the advent of endoscopic technology and advancements in surgical techniques, innovative solutions are now available. However, there are few data on mid-term results after treatment of MLL, especially regarding arthroscopic method. The objective of this study is to evaluate the clinical outcomes of endoscopic debridement combined with percutaneous cutaneo-fascial suture in treating MLL.
METHODS: A single-center retrospective study was conducted at a university teaching hospital investigating patients who underwent arthroscopic management of Morel-Lavallée lesion between 2014 and 2020.Patient demographics, postoperative recovery time, peri- and postoperative complications were investigated. Mid-term follow up clinical and radiological examinations were performed.
RESULTS: The retrospective study included 38 patients aged between 11 and 90 years, with an average age of 50.9 ± 16.9 years. These patients waited an average of 36.6±23.5days to return to work after operation. The average time to follow-up was from 3 to 9 years, averaging 5.0 ± 1.8 years. At the end of follow-up, only one complication of superficial skin necrosis occurred, accounting for 2.6%. The imaging assessment at the final follow-up indicated improvement over the postoperative period for all 38patients.
CONCLUSIONS: In mid-term experience, endoscopic debridement combined with percutaneous cutaneo-fascial suture for MLL management is a safe and effective option.
METHODS: A single-center retrospective study was conducted at a university teaching hospital investigating patients who underwent arthroscopic management of Morel-Lavallée lesion between 2014 and 2020.Patient demographics, postoperative recovery time, peri- and postoperative complications were investigated. Mid-term follow up clinical and radiological examinations were performed.
RESULTS: The retrospective study included 38 patients aged between 11 and 90 years, with an average age of 50.9 ± 16.9 years. These patients waited an average of 36.6±23.5days to return to work after operation. The average time to follow-up was from 3 to 9 years, averaging 5.0 ± 1.8 years. At the end of follow-up, only one complication of superficial skin necrosis occurred, accounting for 2.6%. The imaging assessment at the final follow-up indicated improvement over the postoperative period for all 38patients.
CONCLUSIONS: In mid-term experience, endoscopic debridement combined with percutaneous cutaneo-fascial suture for MLL management is a safe and effective option.
摘要：
目的：Morel-Lavalle病变（MLL）是由剪切力引起的闭合软组织脱套损伤。随着内窥镜技术的出现和外科技术的进步，现在有创新的解决方案。然而,MLL治疗后的中期结果数据很少，特别是关于关节镜的方法。本研究的目的是评估内镜下清创结合经皮皮肤筋膜缝合治疗MLL的临床效果。
方法：在一所大学教学医院进行了一项单中心回顾性研究，调查了2014年至2020年间接受关节镜治疗的Morel-Lavallée病变患者。患者人口统计学，术后恢复时间,研究围手术期及术后并发症。进行中期随访临床和放射学检查。
结果：回顾性研究包括38名年龄在11至90岁之间的患者，平均年龄50.9±16.9岁。这些患者术后平均等待36.6±23.5天恢复工作。平均随访时间为3至9年，平均5.0±1.8年。在后续行动结束时，只有一个浅表皮肤坏死的并发症发生，占2.6%。最后随访时的影像学评估表明，所有38例患者的术后改善。
结论：在中期经验中，内镜下清创联合经皮皮肤筋膜缝合治疗MLL是一种安全有效的选择。
方法：在一所大学教学医院进行了一项单中心回顾性研究，调查了2014年至2020年间接受关节镜治疗的Morel-Lavallée病变患者。患者人口统计学，术后恢复时间,研究围手术期及术后并发症。进行中期随访临床和放射学检查。
结果：回顾性研究包括38名年龄在11至90岁之间的患者，平均年龄50.9±16.9岁。这些患者术后平均等待36.6±23.5天恢复工作。平均随访时间为3至9年，平均5.0±1.8年。在后续行动结束时，只有一个浅表皮肤坏死的并发症发生，占2.6%。最后随访时的影像学评估表明，所有38例患者的术后改善。
结论：在中期经验中，内镜下清创联合经皮皮肤筋膜缝合治疗MLL是一种安全有效的选择。
